Ontology highlight
ABSTRACT:
SUBMITTER: Jakob T
PROVIDER: S-EPMC8095056 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
Jakob Tina T Tesfamariam Yonas Mehari YM Macherey Sascha S Kuhr Kathrin K Adams Anne A Monsef Ina I Heidenreich Axel A Skoetz Nicole N
The Cochrane database of systematic reviews 20201203
<h4>Background</h4>Different bone-modifying agents like bisphosphonates and receptor activator of nuclear factor-kappa B ligand (RANKL)-inhibitors are used as supportive treatment in men with prostate cancer and bone metastases to prevent skeletal-related events (SREs). SREs such as pathologic fractures, spinal cord compression, surgery and radiotherapy to the bone, and hypercalcemia lead to morbidity, a poor performance status, and impaired quality of life. Efficacy and acceptability of the bon ...[more]